Participate

Access for Industry

Innovation is the central goal of EU-OPENSCREEN. We welcome collaborations with the pharmaceutical and biotech sector, specifically in drug discovery, using a pre-competitive model based on open innovation. 

EU-OPENSCREEN provides access to expertise, equipment, and resources for:

  • Drug development support from hit identification to lead optimization
  • Co-development of disruptive technologies in screening and chemical biology
  • Open access compound libraries:
    • the European Chemical Biology Library (ECBL),
    • the Academic Compound Library (EACL) and
    • the Fragment Library (FBLD)
  • Open access European Chemical Biology Database (ECBD) containing structures, physicochemical and biological data
  • Training platforms for cutting-edge drug discovery technologies

Networking is at the heart of innovative business. Our European consortium has the unique opportunity to bring people together and promote innovation and knowledge sharing. Considering your scientific focus and business interest we will help you to find your best R&D partner.

 

The EU-OPENSCREEN Industry Liaison Office (ILO) connects academic researchers with pharmaceutical and biotechnology companies to accelerate drug discovery in Europe. Established within the EU-OPENSCREEN-DRIVE project, the ILO provides a neutral and collaborative platform where scientists and industry partners can work together, share expertise and address complex biomedical challenges.

By facilitating joint projects, coordinating technological collaborations and providing clear frameworks for access, legal agreements and intellectual property, the ILO lowers barriers between academia and industry. Through initiatives such as collaborative technology development and partnerships with academic groups, SMEs and pharma companies, the ILO supports the creation of innovative screening methods and assay technologies.

 If you are intersted in joining the ILO office please contact our Industry Liaison Manager, Robert Harmel, at industry@eu-openscreen.eu .

 

Further information for interested companies from the industry sector

BUILDING INNOVATION IN DRUG DISCOVERY

Learn more about the opportunities for Industry-Academia cooperation!

PDF download (3,1 mB)